Gastro-oesophageal adenocarcinoma

Clinical trials for Gastro-oesophageal adenocarcinoma explained in plain language.

Never miss a new study

Get alerted when new Gastro-oesophageal adenocarcinoma trials appear

Sign up with your email to follow new studies for Gastro-oesophageal adenocarcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Cancer combo trial halted early – what went wrong?

Disease control Stopped early

This phase 2 trial tested a combination of two drugs, niraparib and dostarlimab, in 51 adults with advanced solid tumors that had DNA repair defects or were sensitive to platinum chemotherapy. The goal was to see if the combo could shrink tumors. However, the study was terminated…

Matched conditions: GASTRO-OESOPHAGEAL ADENOCARCINOMA

Phase 2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control

Last updated Jun 27, 2026 08:00 UTC

Gastro-oesophageal adenocarcinoma

Get alerted when new Gastro-oesophageal adenocarcinoma trials appear

Cancer combo trial halted early – what went wrong?